| D-1517-2019 | Class II | Hydrocodone Polistirex and Chlorpheniramine Polistirex Extended-Release Suspension, (equivalent to 1 | July 11, 2019 |
| D-0493-2019 | Class II | Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Fre | January 15, 2019 |
| D-0494-2019 | Class II | infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, Dye-Free | January 15, 2019 |
| D-0495-2019 | Class II | Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Fre | January 15, 2019 |
| D-0336-2019 | Class II | Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye-Fre | November 26, 2018 |
| D-0337-2019 | Class II | Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Fre | November 26, 2018 |
| D-0335-2019 | Class II | infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, Dye-Free | November 26, 2018 |
| D-1126-2017 | Class II | Morphine Sulfate Oral Solution, 100 mg/ 5 mL (20 mg/mL), packaged in a 1 oz. bottle containing 30 mL | June 15, 2017 |